EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Respiratory Oscillometry and Multimodal Lung Function Assessment of Elexacaftor/Tezacaftor/Ivacaftor Response in Children and Young Adults With Cystic Fibrosis

Christos Kogias, Athina Sopiadou, Sotirios Fouzas, Petrina Vantsi, Elissavet-Anna Chrysochoou, Evangelia Desli, Maria Galogavrou, Nikolaos Gasparis, Elpis Hatziagorou

Pediatric Pulmonology · 2026-02 · 61 (2)

DOI: 10.1002/ppul.71527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 22.02.2026. Verfasst von Christos Kogias und 8 weiteren Autor:innen. Beteiligte Einrichtung: Aristotle University of Thessaloniki, Paediatric Pulmonology Unit, 3rd Paediatric Clinic, University General Hospital of Thessaloniki "Hippokration",…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Quinolones, Aminophenols, Benzodioxoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To date, there is no data on forced oscillation technique (FOT) as a tool to evaluate elexacaftor/tezacaftor/ivacaftor (ETI) modulator in young patients with cystic fibrosis (pwCF).

Objective

Our study aimed to assess the effect of a 6‐month ETI treatment on FOT parameters and compare it to the effect on spirometry and nitrogen multiple‐breath washout (N 2 MBW) parameters.

Method

Forty‐nine pwCF (median age 12.39 years, 59.2% male) were assessed with spirometry, N 2 MBW, and FOT before and 3 and 6 months after receiving ETI. The trends in changes of spirometric and FOT parameters were compared among pwCF of different disease severity and in the three patient groups according to their mutation group, that is, F/F, F/non‐F, and non‐F/non‐F. Panel regression was applied to define the predictors of LCI.

Results

A significant change was observed 6 months after receiving ETI in height, weight, BMI, Rs5z‐score, Xs5z‐score, AXz‐score, FEV 1 z‐score, FVCz‐score, FEF 25‐75 z‐score, LCI and sGrs ( p < 0.01). FOT followed a similar trend in parameters' change with spirometry and N 2 MBW three and 6 months after ETI among different severity groups based on LCI ( p < 0.05). Genotype group was found to have a minor role in ETI efficacy; a significant improvement was found in the non‐F/non‐F group in all pulmonary tests ( p < 0.01).

Conclusions

Our preliminary data suggest that oscillometry parameters showed a significant improvement after ETI treatment among all genotype groups. More data are required to assess whether and which FOT parameters could be used as surrogates of LCI or spirometry for the long‐term follow‐up of pwCF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisQuinolonesAminophenolsBenzodioxolesOscillometryPyrrolidinesIndolesPyridinesQuinuclidinesPyrazolesChloride Channel AgonistsHumansChildMaleFemaleSpirometryAdolescentRespiratory Function TestsYoung AdultDrug CombinationsForced Expiratory VolumeTreatment OutcomeQuinolines

Substanzen

QuinolonesAminophenolsBenzodioxolesPyrrolidinesIndolesPyridinesDrug CombinationsQuinuclidineselexacaftor, ivacaftor, tezacaftor drug combinationPyrazoles

Autor:innen und Institutionen

  • Aristotle University of Thessaloniki, Paediatric Pulmonology Unit, 3rd Paediatric Clinic, University General Hospital of Thessaloniki "Hippokration", Thessaloniki, Greece.
  • University of Patras, Paediatric Pulmonology Unit, Paediatric Clinic, University General Hospital of Patras, Patras, Greece.
  • Department of Economics, University of Macedonia of Thessaloniki, Thessaloniki, Greece.

Zitieren

APA

Kogias, C., Sopiadou, A., Fouzas, S., Vantsi, P., Chrysochoou, E. A., Desli, E., Galogavrou, M., Gasparis, N., & Hatziagorou, E. (2026). Respiratory Oscillometry and Multimodal Lung Function Assessment of Elexacaftor/Tezacaftor/Ivacaftor Response in Children and Young Adults With Cystic Fibrosis. Pediatric Pulmonology, 61(2). https://doi.org/10.1002/ppul.71527

Vancouver

Kogias C, Sopiadou A, Fouzas S, Vantsi P, Chrysochoou EA, Desli E, et al. Respiratory Oscillometry and Multimodal Lung Function Assessment of Elexacaftor/Tezacaftor/Ivacaftor Response in Children and Young Adults With Cystic Fibrosis. Pediatric Pulmonology. 2026;61(2). doi:10.1002/ppul.71527

BibTeX
@article{Kogias2026,
  author = {Kogias, Christos and Sopiadou, Athina and Fouzas, Sotirios and Vantsi, Petrina and Chrysochoou, Elissavet-Anna and Desli, Evangelia and Galogavrou, Maria and Gasparis, Nikolaos and Hatziagorou, Elpis},
  title = {Respiratory Oscillometry and Multimodal Lung Function Assessment of Elexacaftor/Tezacaftor/Ivacaftor Response in Children and Young Adults With Cystic Fibrosis},
  journal = {Pediatric Pulmonology},
  year = {2026},
  volume = {61},
  number = {2},
  doi = {10.1002/ppul.71527}
}
Kostenlos starten →